Fatma Smaoui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fatma Smaoui has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Khaoula Rekik
Infectious Diseases Department, Hedi Chaker University Hospital, University of Sfax, Tunisia
4 shared publications - Makram Koubaa
Infectious Diseases Department, Hedi Chaker University Hospital, University of Sfax, Tunisia
4 shared publications - Mounir Ben Jemaa
Department of Infectious Diseases, Hedi Chaker University Hospital, Sfax, Tunisia
4 shared publications - Amal Chakroun
Univ Sfax, Hedi Chaker Univ Hosp, Dept Infect Dis, Sfax, Tunisia
2 shared publications - Chakib Marrakchi
Service des maladies infectieuses, Hôpital universitaire Hédi Chaker, Sfax, Tunisie
2 shared publications - Fatma Hammami
Infectious Diseases Department, Hedi Chaker University Hospital, University of Sfax, Tunisia
2 shared publications
Latest Publications
- 15 November 2025
- Published by Springer Nature
- p. 291-300
The Globalization of Online Fandom: Understanding ACG Fans’ Motivations in the Entertainment Market
- 15 November 2025
- Published by Springer Nature
- p. 291-300
The Globalization of Online Fandom: Understanding ACG Fans’ Motivations in the Entertainment Market
- 1 October 2025
- Published by Springer Nature
- p. 221-244
The Hybrid Identity of Second-Hand Luxury: A Semiotic Approach
- 1 October 2025
- Published by Springer Nature
- p. 221-244
The Hybrid Identity of Second-Hand Luxury: A Semiotic Approach
- 29 November 2024
- Published by Springer Nature
- p. 75-90
‘Why Embrace Augmented Reality Beauty Filters?’: Delving into Young Women’s Motivations
- 29 November 2024
- Published by Springer Nature
- p. 75-90
‘Why Embrace Augmented Reality Beauty Filters?’: Delving into Young Women’s Motivations
- Open Access
- 1 June 2022
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 40 (Suppl 1) , e271
METABOLIC SYNDROME IN POLYCYSTIC OVARY SYNDROME TUNISIAN WOMEN
Objective: Polycystic ovary syndrome (PCOS) is known to reproduce metabolic syndrome (MS) features. This association seems to be heterogeneous. To investigate the profile of MS in patients with PCOS in Tunisia. Design and method: Our study was conducted on women diagnosed with PCOS in 2020 and age matched controls. PCOS and MS diagnosis were made according to the Rotterdam criteria and the definition of the International Diabetes Federation (IDF) respectively. Biochemical tests were analysed via an automated method (Cobas-Roche). Results: Our study was conducted on 96 patients and 108 controls. The median age in patients was at 25 years vs 27 in controls. Only 19.7% of patients met the criteria of MS. However, in controls the prevalence of MS was 12.6%. All MS criteria were more prevalent in PCOS patients compared to controls. We observed in decreasing order: android fat distribution, followed by elevated fasting glucose and decreased HDLc, followed by hypertension, and finally hypertriglyceridemia. Conclusions: In the literature, the prevalence of MS in PCOS was estimated between 22% and 42%. The relatively low prevalence of MS in Tunisian PCOS could be explained by age and geographical heterogeneity of MS distribution. Since, these patients are likely at risk of chronic comorbidities we suggest initiating a specific management.
- 1 June 2022
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 40 (Suppl 1) , e271
Open AccessMETABOLIC SYNDROME IN POLYCYSTIC OVARY SYNDROME TUNISIAN WOMEN
Objective: Polycystic ovary syndrome (PCOS) is known to reproduce metabolic syndrome (MS) features. This association seems to be heterogeneous. To investigate the profile of MS in patients with PCOS in Tunisia. Design and method: Our study was conducted on women diagnosed with PCOS in 2020 and age matched controls. PCOS and MS diagnosis were made according to the Rotterdam criteria and the definition of the International Diabetes Federation (IDF) respectively. Biochemical tests were analysed via an automated method (Cobas-Roche). Results: Our study was conducted on 96 patients and 108 controls. The median age in patients was at 25 years vs 27 in controls. Only 19.7% of patients met the criteria of MS. However, in controls the prevalence of MS was 12.6%. All MS criteria were more prevalent in PCOS patients compared to controls. We observed in decreasing order: android fat distribution, followed by elevated fasting glucose and decreased HDLc, followed by hypertension, and finally hypertriglyceridemia. Conclusions: In the literature, the prevalence of MS in PCOS was estimated between 22% and 42%. The relatively low prevalence of MS in Tunisian PCOS could be explained by age and geographical heterogeneity of MS distribution. Since, these patients are likely at risk of chronic comorbidities we suggest initiating a specific management.
- 3 March 2022
- Published by Elsevier in Metabolism
- Vol. 128, S43
Diabetic foot osteitis: more than double trouble
- 3 March 2022
- Published by Elsevier in Metabolism
- Vol. 128, S43
Diabetic foot osteitis: more than double trouble
- 3 March 2022
- Published by Elsevier in Metabolism
- Vol. 128, S33
Steatosis in chronic hepatitis B and its impact on the therapeutic response to entecavir
- 3 March 2022
- Published by Elsevier in Metabolism
- Vol. 128, S33
Steatosis in chronic hepatitis B and its impact on the therapeutic response to entecavir
- Open Access
- 28 May 2021
- Published by Galenos Yayinevi in Journal of the Turkish-German Gynecological Association
- Vol. 22 (2) , 107-111
Breast tuberculosis: a diagnosis not to be forgotten
Objective: To study the clinical characteristics and imaging features of breast tuberculosis (TB) and to describe treatment. Material and Methods: A retrospective study including all patients hospitalized in the infectious diseases department for breast TB between 1997 and 2018. Results: Twenty-two women, with a mean age of 39 +/- 12 years, were identified. In total, 18 patients were multiparous (81.8%). Both lump and mastalgia were the presenting symptoms in 19 cases (86.3%). Ipsilateral axillary lymphadenopathy was noted in 14 cases (63.6%). The most common finding on ultrasound was a well or poorly defined mass lesion, noted in 17 cases (77.2%), followed by fistulous tracts in seven cases (31.8%). Mammography showed focal, asymmetric breast density in 17 cases (89.5%) and diffuse in two cases (10.5%). The diagnosis was confirmed based on the presence of epithelioid cell granulomas and caseous necrosis in 13 cases (59.1%). Patients received antitubercular therapy for a mean duration of 11 +/- 5 months. The disease evolution was favorable in 20 cases (91%). There were two relapsing cases (9%). Conclusion: Breast TB should be considered in the differential diagnosis of young patients presenting with palpable lump with axillary lymphadenopathy, especially in endemic regions. The diagnosis confirmation usually requires an excision biopsy providing histological or bacteriological evidence.
- 28 May 2021
- Published by Galenos Yayinevi in Journal of the Turkish-German Gynecological Association
- Vol. 22 (2) , 107-111
Open AccessBreast tuberculosis: a diagnosis not to be forgotten
Objective: To study the clinical characteristics and imaging features of breast tuberculosis (TB) and to describe treatment. Material and Methods: A retrospective study including all patients hospitalized in the infectious diseases department for breast TB between 1997 and 2018. Results: Twenty-two women, with a mean age of 39 +/- 12 years, were identified. In total, 18 patients were multiparous (81.8%). Both lump and mastalgia were the presenting symptoms in 19 cases (86.3%). Ipsilateral axillary lymphadenopathy was noted in 14 cases (63.6%). The most common finding on ultrasound was a well or poorly defined mass lesion, noted in 17 cases (77.2%), followed by fistulous tracts in seven cases (31.8%). Mammography showed focal, asymmetric breast density in 17 cases (89.5%) and diffuse in two cases (10.5%). The diagnosis was confirmed based on the presence of epithelioid cell granulomas and caseous necrosis in 13 cases (59.1%). Patients received antitubercular therapy for a mean duration of 11 +/- 5 months. The disease evolution was favorable in 20 cases (91%). There were two relapsing cases (9%). Conclusion: Breast TB should be considered in the differential diagnosis of young patients presenting with palpable lump with axillary lymphadenopathy, especially in endemic regions. The diagnosis confirmation usually requires an excision biopsy providing histological or bacteriological evidence.
- Open Access
omparative analysis between tuberculous meningitis and other forms of extrapulmonary tuberculosis
Tuberculosis is a multisystem disease that may affect any organ or tissue. Tuberculous meningitis (TBM) is the most severe form of tuberculosis and commonly affects the brain. We aimed to study the epidemiological, clinical, therapeutic and evolutionary features of TBM among adults and to compare them with other forms of extrapulmonary tuberculosis. We conducted a retrospective study including all patients hospitalized for extrapulmonary tuberculosis in the infectious disease department in Sfax, Tunisia between 1993 and 2018. We specified the particularities of TBM cases, and we compared them with other extrapulmonary tuberculosis cases. We encountered 78 patients diagnosed with TBM, among 519 patients with extrapulmonary tuberculosis (15%). The median age was 36 years (23-50) years. There were 44 females (56.4%). In comparison with other forms of extrapulmonary tuberculosis, fever [odds ratio (OR)=4.4; p<0.001], asthenia (OR=3.4; p<0.001) and anorexia (OR=2.3; p=0.001) were significantly more frequent in TBM patients. Adverse effects of antitubercular therapy were more frequent among TBM patients (OR=3.1; p<0.001). The mean duration of antitubercular therapy was 15 (12-20) months. Recovery occurred in 66 cases (84.6%), complications in 44 cases (56.4%) and death in 7 cases (9%). Comparison of the disease evolution showed that complications (OR=7.4; p<0.001) and mortality rates (OR=10.7; p<0.001) were significantly more frequent in TBM patients, while recovery was significantly more frequent in other sites of extrapulmonary tuberculosis patients (OR=0.5; p=0.02). In our country, TBM remains a disabling disease. Despite antitubercular therapy, the prognosis was more severe with the occurrence of not only complications but also a high mortality rate in comparison with other forms of extrapulmonary tuberculosis. When clinical and laboratory features suggest the diagnosis of TBM, clinicians should look for tuberculosis elsewhere in the body.
Open Accessomparative analysis between tuberculous meningitis and other forms of extrapulmonary tuberculosis
Tuberculosis is a multisystem disease that may affect any organ or tissue. Tuberculous meningitis (TBM) is the most severe form of tuberculosis and commonly affects the brain. We aimed to study the epidemiological, clinical, therapeutic and evolutionary features of TBM among adults and to compare them with other forms of extrapulmonary tuberculosis. We conducted a retrospective study including all patients hospitalized for extrapulmonary tuberculosis in the infectious disease department in Sfax, Tunisia between 1993 and 2018. We specified the particularities of TBM cases, and we compared them with other extrapulmonary tuberculosis cases. We encountered 78 patients diagnosed with TBM, among 519 patients with extrapulmonary tuberculosis (15%). The median age was 36 years (23-50) years. There were 44 females (56.4%). In comparison with other forms of extrapulmonary tuberculosis, fever [odds ratio (OR)=4.4; p<0.001], asthenia (OR=3.4; p<0.001) and anorexia (OR=2.3; p=0.001) were significantly more frequent in TBM patients. Adverse effects of antitubercular therapy were more frequent among TBM patients (OR=3.1; p<0.001). The mean duration of antitubercular therapy was 15 (12-20) months. Recovery occurred in 66 cases (84.6%), complications in 44 cases (56.4%) and death in 7 cases (9%). Comparison of the disease evolution showed that complications (OR=7.4; p<0.001) and mortality rates (OR=10.7; p<0.001) were significantly more frequent in TBM patients, while recovery was significantly more frequent in other sites of extrapulmonary tuberculosis patients (OR=0.5; p=0.02). In our country, TBM remains a disabling disease. Despite antitubercular therapy, the prognosis was more severe with the occurrence of not only complications but also a high mortality rate in comparison with other forms of extrapulmonary tuberculosis. When clinical and laboratory features suggest the diagnosis of TBM, clinicians should look for tuberculosis elsewhere in the body.
- 25 February 2017
- Published by Morressier GmbH
Clinical Profile of Patients Hospitalized for Delirium
- 1 November 2007
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 134 (11) , 871-872
Sexualité des adolescents lycéens en milieu rural en Tunisie
- 1 November 2007
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 134 (11) , 871-872
Sexualité des adolescents lycéens en milieu rural en Tunisie